#United States #Nashville #Cancer Research #Clinical Trials #Tennessee Oncology

Tennessee Oncology Launches New Clinical Research Unit

On November 5, 2025, Tennessee Oncology, a prominent name in cancer care, unveiled the Greco-Hainsworth Tennessee Oncology Centers for Research in Nashville. This new facility is a strategic expansion of their existing clinical trials program, aimed at facilitating early-stage cancer drug development.

Leadership and Mission

The center will be directed by esteemed professionals Jeffery Russell, M.D., Ph.D., MBA, and Joseph Merriman, M.D. Under their guidance, a dedicated team of 20 research specialists will work to transform cancer treatment paradigms, allowing patients to access advanced therapies typically only available at large academic institutions.

In Dr. Russell's words, "By conducting early-phase clinical trials where patients already receive their care, we can expand access to potentially life-changing therapies and enhance continuity of care for our patients." This initiative embodies Tennessee Oncology's long-term commitment to innovation in cancer treatment and patient accessibility.

Importance of Early-Phase Trials

Early-phase research is crucial as it explores how new medications can impact human patients in terms of safety and optimal dosage. Conducting these studies within community oncology practices is a game-changer; it extends opportunities beyond traditional academic settings, making it easier for patients to participate in clinical trials without the burden of long-distance travel. This localized approach encourages greater involvement and diversity in trial enrollment, ultimately resulting in quicker access to new therapies.

Dr. Ian W. Flinn, Chief Scientific Officer at Tennessee Oncology, shared his enthusiasm for the new unit, stating, "Establishing an early phase program at Tennessee Oncology allows us to bring the most promising cancer therapies to patients at the very start of development." This goal highlights the center's mission to innovate and improve patient care within their communities.

Leading the Future of Cancer Care

The Greco-Hainsworth Research Centers, which were initiated in 2023, are currently overseeing approximately 100 clinical trials, with an increasing number of early-phase studies being conducted across 22 locations in Tennessee and parts of Georgia. This newly established unit at Elliston Place Plaza will become a pivotal center for developing next-generation cancer treatments.

The facility is strategically located within the community, allowing patients consistent access to their established healthcare teams, thereby enhancing their support systems during potentially challenging treatment journeys.

Conclusion

Tennessee Oncology's launch of this early-phase clinical research unit signifies a major step towards making advanced cancer therapies accessible to more patients. As one of the country's largest community-based cancer care practices, they are not just treating patients but empowering them with the latest scientific advancements in oncology. As research continues to evolve, Tennessee Oncology stands as a beacon of hope, committed to enhancing the lives of those battling cancer right in their own neighborhoods. For further information, visit Tennessee Oncology's website.